Sponsor of the Day:
Jerkmate
https://www.webmd.com/cancer/myelofibrosis-causes-risk-factors
Myelofibrosis: Symptoms, Causes, Diagnosis, and Treatment
Myelofibrosis is a rare kind of blood cancer that starts in your marrow, a spongy tissue inside your bones that makes blood cells. Learn more about the...
symptoms causes diagnosismyelofibrosistreatment
https://www.cancerresearchuk.org/about-cancer/myelofibrosis
Myelofibrosis | Cancer Research UK
Myelofibrosis is a rare blood cancer. It causes scarring of the bone marrow which can develop into acute leukaemia in some people.
cancer research ukmyelofibrosis
https://www.cms.gov/medicare/coverage/evidence/stem-cell-transplant-myelofibrosis
Allogeneic Hematopoietic Stem Cell Transplant for Myelofibrosis | CMS
The NCD for Stem Cell Transplantation Multiple Myeloma (MM), Myelofibrosis (MF) and Sickle Cell Disease (SCD), released by CMS on January 27, 2016, concluded...
allogeneic hematopoietic stemcell transplantmyelofibrosiscms
https://www.statnews.com/2025/12/07/ash-meeting-newsletter-fulcrum-sickle-cell-pill-incyte-myelofibrosis-data/
A promising sickle cell pill and a new way to treat myelofibrosis | STAT
Dec 7, 2025 - At ASH 2025, Fulcrum presented promising data on a sickle cell pill and Incyte is pioneering a new way to treat myelofibrosis.
sickle cellnew waypromisingpilltreat
https://us.gsk.com/en-us/company/oncology/myelofibrosis/
Myelofibrosis | GSK US
Myelofibrosis is a rare and potentially fatal bone marrow cancer, affecting ~25,000 people in the U.S.
gsk usmyelofibrosis
https://www.biospace.com/drug-development/karyopharm-slides-as-mixed-myelofibrosis-results-cloud-regulatory-road
Karyopharm Slides as Mixed Myelofibrosis Results Cloud Regulatory Road - BioSpace
Mar 25, 2026 - Missing one of its co-primary endpoints could make it difficult for Karyopharm Therapeutics to score conventional approval for Xpovio in myelofibrosis,...
karyopharmslidesmixedmyelofibrosisresults